We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+1.9%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$559M
AUM Growth
-$480M
(-46%)
Cap. Flow
-$438M
Cap. Flow
% of AUM
-78.37%
Top 10 Holdings %
Top 10 Hldgs %
15.86%
Holding
756
New
216
Increased
66
Reduced
143
Closed
331
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALLK
Allakos
ALLK
|
+$25.1M |
| 2 |
Merck
MRK
|
+$9.57M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$9.37M |
| 4 |
BridgeBio Pharma
BBIO
|
+$9.02M |
| 5 |
Marvell Technology
MRVL
|
+$7.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$10.5M |
| 2 |
Citigroup
C
|
+$10.5M |
| 3 |
Microsoft
MSFT
|
+$9.87M |
| 4 |
OPTU
Optimum Communications Inc
OPTU
|
+$9.41M |
| 5 |
AES
AES
|
+$7.92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.93% |
| 2 | Consumer Discretionary | 17.95% |
| 3 | Healthcare | 12.14% |
| 4 | Communication Services | 8.7% |
| 5 | Financials | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Arch Capital
ACGL
$33.7B
| $219K | 0.04% |
+4,922
| New | +$209K |
|
402
Warby Parker
WRBY
$3.16B
| $219K | 0.04% |
+4,706
| New | +$245K |
|
403
First Horizon
FHN
$12.3B
| $217K | 0.04% |
+13,261
| New | +$221K |
|
404
SiriusXM
SIRI
$10.2B
| $217K | 0.04% |
3,423
-69,419
| -95% | -$4.34M |
|
405
Wolfspeed
WOLF
$1.5B
| $216K | 0.04% |
+1,934
| New | +$216K |
|
406
Regal Rexnord
RRX
$12.2B
| $215K | 0.04% |
1,263
-737
| -37% | -$117K |
|
|
MAXR
407
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $215K | 0.04% |
+7,265
| New | +$211K |
|
408
Ironwood Pharmaceuticals
IRWD
$706M
| $214K | 0.04% |
18,361
-48,509
| -73% | -$595K |
|
409
Akamai
AKAM
$17.4B
| $211K | 0.04% |
+1,807
| New | +$199K |
|
410
Southwest Gas
SWX
$6.68B
| $211K | 0.04% |
+3,016
| New | +$208K |
|
|
SGEN
411
DELISTED
Seagen Inc. Common Stock
SGEN
| $208K | 0.04% |
1,344
-4,299
| -76% | -$720K |
|
|
AGNT
412
AGNT Inc
AGNT
$690M
| $207K | 0.04% |
+6,132
| New | +$253K |
|
413
Petrobras
PBR
$120B
| $207K | 0.04% |
18,809
-88,615
| -82% | -$936K |
|
|
MDRX
414
DELISTED
Veradigm Inc. Common Stock
MDRX
| $206K | 0.04% |
11,177
-24,723
| -69% | -$393K |
|
415
PG&E
PCG
$37.5B
| $203K | 0.04% |
16,696
-206,407
| -93% | -$2.42M |
|
416
Omnicell
OMCL
$1.66B
| $201K | 0.04% |
1,114
-2,886
| -72% | -$501K |
|
417
W.W. Grainger
GWW
$59.8B
| $200K | 0.04% |
+386
| New | +$182K |
|
|
ZNGA
418
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $197K | 0.04% |
30,712
-736
| -2% | -$5.08K |
|
419
ING
ING
$103B
| $177K | 0.03% |
12,729
-101,986
| -89% | -$1.48M |
|
|
FLG
420
Flagstar Bank National Association
FLG
$5.98B
| $175K | 0.03% |
4,786
-56,681
| -92% | -$2.16M |
|
421
Barclays
BCS
$95.8B
| $160K | 0.03% |
15,458
-52,042
| -77% | -$546K |
|
422
Hecla Mining
HL
$11B
| $120K | 0.02% |
23,023
-80,707
| -78% | -$451K |
|
423
Butterfly Network
BFLY
$2.25B
| $100K | 0.02% |
+14,982
| New | +$132K |
|
424
Lufax Holding
LU
$1.27B
| $65K | 0.01% |
2,881
-59,059
| -95% | -$1.55M |
|
425
Clean Energy Fuels
CLNE
$412M
| $62K | 0.01% |
10,040
-237,587
| -96% | -$1.86M |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q4 2021 Portfolio in Review
As of Q4 2021, Seven Eight Capital held 756 positions worth $559M, down 46% from $1.04B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Seven Eight Capital withdrew a net $438M in Q4 2021, closing 331 positions and reducing 143 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $10.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Seven Eight Capital opened a new position in Allakos worth $3M.
- Seven Eight Capital's largest Q4 2021 buy was Allakos: 306,723 shares worth $3M.
- Seven Eight Capital added most to Mimecast Limited in Q4 2021, an estimated $6.07M increase.
- Seven Eight Capital's biggest Q4 2021 reduction was Fidelity National Information Services, cutting an estimated $7.12M.
- Seven Eight Capital fully exited Bristol-Myers Squibb in Q4 2021, selling an estimated $10.5M.
- Seven Eight Capital's ten largest holdings make up 16% of its $559M portfolio in Q4 2021.
- Seven Eight Capital opened 216 new positions and closed 331 in Q4 2021.
- Seven Eight Capital's portfolio value fell 46% quarter-over-quarter to $559M.
Based on Seven Eight Capital's 13F filing for Q4 2021, filed 14 Feb 2022.